oncology drugs

CAMBRIDGE, Mass., April 7, 2026 Nuvalent, Inc. has announced the submission of a New Drug Application (NDA) to the...

OTTAWA, Canada, February 2026 — Canada’s Drug Agency (CDA-AMC) has issued a conditional reimbursement recommendation for Opdivo® (nivolumab) plus...